These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17001069)

  • 1. Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies.
    Fernández-Avilés F; Carreras E; Urbano-Ispizua A; Rovira M; Martínez C; Gaya A; Granell M; Ramiro L; Gallego C; Hernando A; Segura S; García L; González M; Valverde M; Montserrat E
    J Clin Oncol; 2006 Oct; 24(30):4855-61. PubMed ID: 17001069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
    Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
    Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The autologous transplantation of hematopoietic precursors on an outpatient basis: an analysis of its feasibility at the Hospital Clínic de Barcelona].
    Rives S; Carreras E; Rovira M; Montoto S; Urbano-Ispizua A; Martínez C; Perales M; Alvarez A; Esteve J; González M; Montserrat E
    Med Clin (Barc); 1999 Sep; 113(6):201-4. PubMed ID: 10472607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition.
    Svahn BM; Remberger M; Heijbel M; Martell E; Wikström M; Eriksson B; Milovsavljevic R; Mattsson J; Ringdén O
    Transplantation; 2008 Apr; 85(7):1000-7. PubMed ID: 18408581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late infectious complications after high-dose therapy and autologous blood stem cell transplantation].
    Metzner B; Grüneisl R; Gebauer W; Reschke D; Ost E; Müller TH; Reichert D; Rosien B; Del Valle F; Zirpel I; Kohse KP; Schunter F; Illiger HJ
    Med Klin (Munich); 2002 Nov; 97(11):650-8. PubMed ID: 12434273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
    Eleutherakis-Papaiakovou E; Kostis E; Migkou M; Christoulas D; Terpos E; Gavriatopoulou M; Roussou M; Bournakis E; Kastritis E; Efstathiou E; Dimopoulos MA; Papadimitriou CA
    Am J Hematol; 2010 Nov; 85(11):863-7. PubMed ID: 20882526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient high-dose melphalan in multiple myeloma patients.
    Kassar M; Medoff E; Seropian S; Cooper DL
    Transfusion; 2007 Jan; 47(1):115-9. PubMed ID: 17207239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial.
    Reich G; Cornely OA; Sandherr M; Kubin T; Krause S; Einsele H; Thiel E; Bellaire T; Dörken B; Maschmeyer G
    Br J Haematol; 2005 Jul; 130(2):265-70. PubMed ID: 16029455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
    de la Rubia J; Montesinos P; Martino R; Jarque I; Rovira M; Vázquez L; López J; Batlle M; de la Cámara R; Juliá A; Lahuerta JJ; Debén G; Díaz J; García R; Sanz MA
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):512-6. PubMed ID: 19285640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.
    Elting LS; Shih YC; Stiff PJ; Bensinger W; Cantor SB; Cooksley C; Spielberger R; Emmanoulides C
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):806-13. PubMed ID: 17580258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma.
    Herrmann RP; Trent M; Cooney J; Cannell PK
    Bone Marrow Transplant; 1999 Dec; 24(11):1213-7. PubMed ID: 10642811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.
    Viscoli C; Cometta A; Kern WV; Bock R; Paesmans M; Crokaert F; Glauser MP; Calandra T;
    Clin Microbiol Infect; 2006 Mar; 12(3):212-6. PubMed ID: 16451406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial.
    Svahn BM; Bjurman B; Myrbäck KE; Aschan J; Ringdén O
    Bone Marrow Transplant; 2000 Nov; 26(10):1057-60. PubMed ID: 11108303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study.
    Jagasia MH; Greer JP; Morgan DS; Mineishi S; Kassim AA; Ruffner KL; Chen H; Schuening FG
    Bone Marrow Transplant; 2005 Jun; 35(12):1165-9. PubMed ID: 15880129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies.
    Celebi H; Akan H; Akçağlayan E; Ustün C; Arat M
    Bone Marrow Transplant; 2000 Jul; 26(2):211-4. PubMed ID: 10918433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
    Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
    Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients.
    Mathew S; Adel N; Rice RD; Panageas K; Duck ET; Comenzo RL; Kewalramani T; Nimer SD
    Bone Marrow Transplant; 2010 Oct; 45(10):1522-7. PubMed ID: 20062102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical care for patients receiving autologous hematopoietic stem cell transplantation in the home setting.
    Herrmann RP; Leather M; Leather HL; Leen K
    Oncol Nurs Forum; 1998 Sep; 25(8):1427-32. PubMed ID: 9766296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia.
    Ferrara F; Mele G; Palmieri S; Pedata M; Copia C; Riccardi C; Izzo T; Criscuolo C; Musto P
    Hematol Oncol; 2009 Dec; 27(4):198-202. PubMed ID: 19475701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.